Markets:
DJIA +257.860.83%
NASDAQ +260.071.97%
S&P +52.941.39%
Featured Stocks:
HBP +0.61% 3.28
IWM +0.44% 214.39
SOCL +2.51% 66.63
IIPR +3.37% 195.62

NYSE: BDX

Article Index

Rising Rates Are a "Wild Card." Here's How to Play It…

By , Chief Investment Strategist, Money Map Report -

This week's trading featured a three-day losing streak for U.S. markets on fears that the Fed may hike interest rates earlier than expected, with the Dow, S&P 500, and Nasdaq shedding 1.24%, 1.5%, and 1.57% respectively.

Bring it on!

I've pointed out repeatedly since the financial crisis began that the "good is bad" meme followed by traders - which triggers market dips with every piece of significant good news, thanks to paranoia that the Fed will seize on that news to raise rates - only creates buying opportunities for investors with the right tactics.

Today, that could be you.

The week's collapse creates three massive opportunities. I'm going to explain to you exactly what they are, why they exist, and most importantly, why they're being overlooked by insiders and mainstream investors alike.

Here's what they're all missing - and here's your opportunity...

Ignore "Ebola Stocks" Hype – This Medical Tech Leader Is Already Set Up to Treat the Next Major Outbreak

By , Chief Investment Strategist, Money Map Report -

ebola stocks

The first U.S. case of the deadly Ebola virus has been confirmed in a patient in Dallas, Texas, and the news sent "Ebola stocks" - the companies racing to get approval for treatment - up as much as 20% in after-hours trading Tuesday.

But instead of trying to guess which company is going to come through with a cure, I recommend you concentrate on companies making the best medical testing, diagnosis, and drug delivery systems.

Like this one – it’s going to power sharply higher in the next 12 months…